vinpocetine has been researched along with Brain Ischemia in 42 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (23.81) | 18.7374 |
1990's | 3 (7.14) | 18.2507 |
2000's | 15 (35.71) | 29.6817 |
2010's | 13 (30.95) | 24.3611 |
2020's | 1 (2.38) | 2.80 |
Authors | Studies |
---|---|
Koike, K; Li, W; Ohmoto, T; Sasaki, T | 1 |
Cao, W; Fan, C; Guo, X; Hou, B; Jiang, C; Li, D; Ren, H; Wan, Z; Wang, D; Wang, G; Yan, G; Zhao, L | 1 |
Chen, J; Gong, Z; Hao, J; Liu, S; Ma, X; Shi, FD; Wei, C; Yan, C; Yao, Y; Zang, D; Zhang, F | 1 |
Jincai, W; Kaihua, Z; Tingfang, D; Xiaohong, L; Yongheng, Z; Zhongmin, L | 1 |
Abdrakhmanova, EK; Fedin, AI; Mironova, OP; Parfenov, AS; Starykh, EP; Starykh, EV | 1 |
Gao, L; Tang, J; Wang, H; Wei, Z; Zhang, K; Zhao, L | 1 |
Makarova, LM; Mirzoian, RS; Pogorelyĭ, VE; Prikhod'ko, MA; Skachilova, SIa | 1 |
Yang, L; Zhang, L | 1 |
Darmanyan, AP; Kurkin, DV; Litvinov, AA; Ozerov, AA; Tyurenkov, IN; Volotova, EV | 1 |
Chelysheva, LV; Doronin, BM; Klimova, LA; Kornach, NV; Popova, TF; Volkova, II | 1 |
Grigor'eva, AN; Nesterova, MV | 1 |
Balakishieva, FK; Musaev, AV | 1 |
Alifirova, VM; Vaizova, OE; Vengerovsky, AI | 1 |
Medhi, B; Modi, M; Patyar, S; Prakash, A | 1 |
Airaksinen, A; Gulyás, B; Halldin, C; Hillert, J; Kostulas, K; Lindström, P; Schain, M; Tóth, M; Vas, A | 1 |
Chukanova, AS; Chukanova, EI; Khodzhamzharov, BÉ | 1 |
Dézsi, L; Kárpáti, E; Kis-Varga, I; Komlódi, Z; Nagy, J | 1 |
Alexy, T; Czopf, J; Horváth, B; Késmárky, G; Márton, Z; Nagy, F; Szapáry, L; Szóts, M; Tóth, K | 1 |
Hadjiev, D | 1 |
Gaĭkova, ON; Ianishevskiĭ, SN; Onishchenko, LS | 1 |
Bagoly, E; Fehér, G; Szapáry, L | 1 |
Valikovics, A | 1 |
Gaikova, ON; Onishchenko, LS; Yanishevskii, SN | 1 |
Alifirova, VM; Vaizova, OE; Vengerovskiĭ, AI | 1 |
Bereczki, D; Fekete, I | 2 |
Kovács, G | 1 |
Bałuka-Horecka, M | 1 |
Bauer, J; Kalvach, P; Ságová, V | 1 |
Hamajo, K; Kakihana, M; Nagaoka, A; Shibota, M; Suno, M | 1 |
Braun, P | 1 |
Nikolov, R; Nikolova, M | 1 |
Ishchenko, MM; Korol'kov, OS | 1 |
Balkay, L; Bereczki, D; Bönöczk, P; Boros, I; Csiba, L; Emri, M; Fekete, I; Galuska, L; Gulyás, B; Kerényi, L; Lehel, S; Márián, T; Molnár, T; Szakáll, S; Trón, L; Varga, J; Vas, A | 1 |
Doronin, BM; Feigin, VL; Gribatcheva, EV; Popova, TF; Tchervov, DV | 1 |
Bazhenova, TG; Plotnikov, MB; Plotnikova, TM | 1 |
Krieglstein, J; Rischke, R | 1 |
Boda, J; Czakó, L; Fügi, S; Karsay, K; Koncz, I; Kovács, A; Maczkó, PA | 1 |
Ishchenko, AM; Ishchenko, MM; Shkrobot, SI | 1 |
Malyĭ, VD; Vinichuk, SM | 1 |
Burtsev, EM; Tugutov, AI | 1 |
8 review(s) available for vinpocetine and Brain Ischemia
Article | Year |
---|---|
Anti-inflammatory effects of vinpocetine in atherosclerosis and ischemic stroke: a review of the literature.
Topics: Anti-Inflammatory Agents; Atherosclerosis; Brain Ischemia; Humans; Stroke; Vinca Alkaloids | 2014 |
Role of vinpocetine in cerebrovascular diseases.
Topics: Animals; Brain Ischemia; Cerebrovascular Disorders; Humans; Memory; Neuroprotective Agents; Nootropic Agents; Stroke; Vinca Alkaloids | 2011 |
[Current possibilities of the correction of oxidative stress in acute brain ischaemia].
Topics: Antioxidants; Brain Ischemia; Humans; Oxidative Stress; Pentoxifylline; Piracetam; Reactive Oxygen Species; Vinca Alkaloids | 2012 |
Vinpocetine. Monograph.
Topics: Alzheimer Disease; Brain Ischemia; Calcium Channel Blockers; Hearing Disorders; Humans; Neuroprotective Agents; Nootropic Agents; Randomized Controlled Trials as Topic; Stroke; Vasodilator Agents; Vinca Alkaloids | 2002 |
Asymptomatic ischemic cerebrovascular disorders and neuroprotection with vinpocetine.
Topics: Brain Ischemia; Clinical Trials as Topic; Diagnosis, Differential; Humans; Magnetic Resonance Imaging; Neuroprotective Agents; Prognosis; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vinca Alkaloids | 2003 |
[The role of vinpocetine in the treatment of cerebrovascular diseases based in human studies].
Topics: Acute Disease; Brain Ischemia; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Disease; Glucose; Hemorheology; Humans; Neuroprotective Agents; Nootropic Agents; Quality of Life; Stroke; Treatment Outcome; Vasodilator Agents; Vinca Alkaloids | 2007 |
Vinpocetine for acute ischaemic stroke.
Topics: Brain Ischemia; Calcium Channel Blockers; Humans; Neuroprotective Agents; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Vasodilator Agents; Vinca Alkaloids | 2008 |
Vinpocetine for acute ischaemic stroke.
Topics: Brain Ischemia; Calcium Channel Blockers; Humans; Neuroprotective Agents; Platelet Aggregation Inhibitors; Stroke; Vasodilator Agents; Vinca Alkaloids | 2000 |
4 trial(s) available for vinpocetine and Brain Ischemia
Article | Year |
---|---|
[Effect of vinpocetin on the hemorheologic parameters in patients with chronic cerebrovascular disease].
Topics: Aged; Antihypertensive Agents; Blood Viscosity; Brain Ischemia; Chronic Disease; Drug Administration Schedule; Erythrocyte Aggregation; Female; Hematocrit; Hemorheology; Humans; Infusions, Intravenous; Male; Middle Aged; Treatment Outcome; Vasodilator Agents; Vinca Alkaloids | 2003 |
[Investigation of the effect of vinpocetine on cerebral blood flow and cognitive functions].
Topics: Administration, Oral; Adult; Blood Flow Velocity; Brain Ischemia; Cerebrovascular Circulation; Cognition; Cognition Disorders; Dementia, Vascular; Female; Humans; Male; Middle Aged; Middle Cerebral Artery; Neuroprotective Agents; Nootropic Agents; Pilot Projects; Psychometrics; Severity of Illness Index; Stroke; Ultrasonography, Doppler, Transcranial; Vasodilator Agents; Vinca Alkaloids | 2007 |
[The effect of a single-dose intravenous vinpocetine on brain metabolism in patients with ischemic stroke].
Topics: Aged; Brain; Brain Ischemia; Glucose; Humans; Infusions, Intravenous; Middle Aged; Neuroprotective Agents; Stroke; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Vasodilator Agents; Vinca Alkaloids | 2001 |
Vinpocetine treatment in acute ischaemic stroke: a pilot single-blind randomized clinical trial.
Topics: Acute Disease; Aged; Brain Ischemia; Dextrans; Drug Combinations; Feasibility Studies; Female; Humans; Male; Middle Aged; Molecular Weight; Neuroprotective Agents; Pilot Projects; Severity of Illness Index; Single-Blind Method; Stroke; Treatment Outcome; Vinca Alkaloids | 2001 |
30 other study(ies) available for vinpocetine and Brain Ischemia
Article | Year |
---|---|
Evaluation of canthinone alkaloids as cerebral protective agents.
Topics: Animals; Brain; Brain Ischemia; Drug Evaluation, Preclinical; Gerbillinae; Indole Alkaloids; Neuroprotective Agents; Structure-Activity Relationship | 2016 |
Neuroprotective Effects of Vinpocetine Against Ischemia-Reperfusion Injury Via Inhibiting NLRP3 Inflammasome Signaling Pathway.
Topics: Animals; Brain Ischemia; Infarction, Middle Cerebral Artery; Inflammasomes; Ischemic Stroke; Mice; Neuroprotective Agents; NLR Family, Pyrin Domain-Containing 3 Protein; Reperfusion Injury; Signal Transduction; Sulfonamides | 2023 |
Vinpocetine Inhibits NF-κB-Dependent Inflammation in Acute Ischemic Stroke Patients.
Topics: Adult; Aged; Brain Ischemia; C-Reactive Protein; Cytokines; Female; Follow-Up Studies; Gene Expression Regulation; Humans; Inflammation; Leukocytes, Mononuclear; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuroprotective Agents; NF-kappa B; RNA, Messenger; Statistics, Nonparametric; Stroke; Time Factors; Vinca Alkaloids | 2018 |
Effects of vinpocetine and ozagrel on behavioral recovery of rats after global brain ischemia.
Topics: Animals; Brain Ischemia; CA1 Region, Hippocampal; Cell Count; Male; Maze Learning; Methacrylates; Neurons; Neuroprotective Agents; Neuropsychological Tests; Random Allocation; Rats; Rats, Sprague-Dawley; Treatment Outcome; Vinca Alkaloids | 2014 |
[Pharmacotherapy of endothelial dysfunction in patients with atherosclerotic brain ischemia].
Topics: Aged; Aged, 80 and over; Antioxidants; Brain Ischemia; Calcium Channel Blockers; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Intracranial Arteriosclerosis; Male; Middle Aged; Thioctic Acid; Treatment Outcome; Vinca Alkaloids | 2013 |
Anti-inflammatory effects of vinpocetine on the functional expression of nuclear factor-kappa B and tumor necrosis factor-alpha in a rat model of cerebral ischemia-reperfusion injury.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain Edema; Brain Infarction; Brain Ischemia; Male; NF-kappa B; Rats, Wistar; Reperfusion Injury; RNA, Messenger; Tumor Necrosis Factor-alpha; Vinca Alkaloids | 2014 |
[Effect of a new derivative of glutamic and apovincaminic acids on brain metabolism in post-ischemic period].
Topics: Acidosis, Lactic; Animals; Blood Glucose; Brain; Brain Ischemia; Cats; Glutamic Acid; Glycine; Lactic Acid; Neuroprotective Agents; Oxygen Consumption; Reperfusion Injury; Vinca Alkaloids | 2014 |
[COMPARATIVE CEREBROPROTECTIVE EFFECT OF PREVENTIVE ADMINISTRATION OF MAGNESIUM HYDROXYBUTYRATE VERSUS MAGNESIUM SULFATE AND CAVINTON IN RATS WITH COMMON CAROTID ARTERY OCCLUSION].
Topics: Animals; Avoidance Learning; Brain Edema; Brain Ischemia; Carotid Artery, Common; Cerebrovascular Circulation; Coronary Occlusion; Dose-Response Relationship, Drug; Hydroxybutyrates; Magnesium; Magnesium Sulfate; Male; Maze Learning; Motor Activity; Neuroprotective Agents; Rats; Rats, Wistar; Survival Analysis; Vinca Alkaloids | 2016 |
[The results of clinical study of cavinton efficacy inpatients with chronic brain ischemia].
Topics: Antihypertensive Agents; Brain Ischemia; Chronic Disease; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Inpatients; Middle Aged; Nootropic Agents; Treatment Outcome; Vinca Alkaloids | 2008 |
[Effect of cavinton forte on the cerebral hemodynamic and autoregulation mechanisms of cerebral blood flow in patients with chronic cerebral ischemia].
Topics: Administration, Oral; Aged; Aged, 80 and over; Brain Ischemia; Cerebrovascular Circulation; Chronic Disease; Dose-Response Relationship, Drug; Follow-Up Studies; Homeostasis; Humans; Regional Blood Flow; Treatment Outcome; Ultrasonography, Doppler, Transcranial; Vasodilator Agents; Vinca Alkaloids | 2009 |
[Electrophoresis of vasoactive drugs in the treatment and rehabilitation of patients with cerebral ischemic diseases].
Topics: Adult; Aged; Antihypertensive Agents; Brain Ischemia; Electrophoresis; Female; Humans; Male; Middle Aged; Pentoxifylline; Treatment Outcome; Vasodilator Agents; Vinca Alkaloids | 2010 |
[Endothelium-protective effects of vinpocetine, pentoxifylline and enalapril in patients with chronic brain ischemia].
Topics: Adult; Aged; Antihypertensive Agents; Brain Ischemia; Case-Control Studies; Cerebrovascular Circulation; Cholesterol; Chronic Disease; Dose-Response Relationship, Drug; Enalapril; Endothelium, Vascular; Fibrinogen; Humans; Middle Aged; Pentoxifylline; Treatment Outcome; Vasodilation; Vasodilator Agents; Vinca Alkaloids; von Willebrand Factor | 2011 |
Evolution of microglial activation in ischaemic core and peri-infarct regions after stroke: a PET study with the TSPO molecular imaging biomarker [((11))C]vinpocetine.
Topics: Adult; Aged; Biomarkers; Brain Ischemia; Carbon Radioisotopes; Functional Neuroimaging; Humans; Infarction; Magnetic Resonance Imaging; Male; Microglia; Middle Aged; Molecular Imaging; Organ Size; Positron-Emission Tomography; Radioligand Assay; Receptors, GABA; Stroke; Time Factors; Up-Regulation; Vinca Alkaloids | 2012 |
[Neuroprotective effects of vinpocetine in vivo and in vitro. Apovincaminic acid derivatives as potential therapeutic tools in ischemic stroke].
Topics: Animals; Brain Ischemia; Disease Models, Animal; Humans; Ischemic Attack, Transient; Neuroprotective Agents; Rats; Stroke; Structure-Activity Relationship; Vinca Alkaloids | 2002 |
[Changes in the focus of experimental ischemic stroke under the influence of neuroprotective drugs].
Topics: Amino Acids; Animals; Brain; Brain Ischemia; Glycerylphosphorylcholine; Male; Neuroprotective Agents; Nootropic Agents; Piracetam; Rats; Stroke; Vinca Alkaloids | 2006 |
Changes at the focus of experimental ischemic stroke treated with neuroprotective agents.
Topics: Amino Acids; Animals; Brain; Brain Ischemia; Glycerylphosphorylcholine; Male; Neuroprotective Agents; Nootropic Agents; Piracetam; Rats; Recovery of Function; Stroke; Vinca Alkaloids | 2008 |
[An effect of vinpocetine (cavinton) on endothelium function in patients with chronic cerebral ischemia].
Topics: Aged; Brachial Artery; Brain Ischemia; Calcium Channel Blockers; Cerebrovascular Circulation; Chronic Disease; Dose-Response Relationship, Drug; Endothelium, Vascular; Follow-Up Studies; Humans; Injections, Intravenous; Middle Aged; Treatment Outcome; Vasodilation; Vasodilator Agents; Vinca Alkaloids | 2006 |
Observations with cavinton treatment in acute cerebral ischaemic conditions.
Topics: Acute Disease; Aged; Aged, 80 and over; Brain Ischemia; Female; Humans; Male; Middle Aged; Vinca Alkaloids | 1984 |
[Effects of Cavinton on the pathological changes in ischemic brain changes starting as an acute disease].
Topics: Acute Disease; Adult; Aged; Brain Ischemia; Drug Evaluation; Female; Humans; Male; Middle Aged; Vinca Alkaloids | 1982 |
[Cavinton in the therapy of cerebrovascular disorders].
Topics: Aged; Brain Ischemia; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Vasodilator Agents; Vinca Alkaloids | 1982 |
[Protective effect of vinpocetine on experimental brain ischemia].
Topics: Adenosine Triphosphate; Animals; Brain Ischemia; Cerebral Cortex; Injections, Intraperitoneal; Lactates; Lactic Acid; Male; Rats; Rats, Inbred Strains; Vasodilator Agents; Vinca Alkaloids | 1982 |
Cerebral regulation-cerebral regulators.
Topics: Brain Ischemia; Cerebrovascular Circulation; Humans; Hungary; Vasodilator Agents; Vinca Alkaloids; Vincamine | 1980 |
[Antihypoxic action of orotic acid].
Topics: Animals; Brain Ischemia; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hexobarbital; Hypoxia; Mice; Mice, Inbred Strains; Orotic Acid; Vasodilator Agents; Vinca Alkaloids | 1981 |
[The effect of kavinton and korglycon on the central and cerebral hemodynamics of patients with an ischemic stroke in stenoses and occlusions of the major cerebral arteries].
Topics: Adult; Aged; Antihypertensive Agents; Brain Ischemia; Cerebral Arterial Diseases; Drug Evaluation; Drug Therapy, Combination; Female; Hemodynamics; Humans; Intracranial Arteriosclerosis; Male; Middle Aged; Strophanthins; Vasodilator Agents; Vinca Alkaloids | 1998 |
[The evaluation of the efficacy of antihypoxic agents lowering hemoglobin oxygen affinity in acute cerebral ischemia].
Topics: Acute Disease; Animals; Antioxidants; Ascorbic Acid; Benzimidazoles; Brain Ischemia; Drug Evaluation, Preclinical; Hemoglobins; Hypoxia, Brain; Oxygen; Rats; Sodium Oxybate; Vasodilator Agents; Vinca Alkaloids | 1991 |
Protective effect of vinpocetine against brain damage caused by ischemia.
Topics: Animals; Brain Damage, Chronic; Brain Ischemia; Cerebrovascular Circulation; Hippocampus; Injections, Intraperitoneal; Male; Rats; Rats, Inbred Strains; Regional Blood Flow; Vasodilator Agents; Vinca Alkaloids | 1991 |
Examination of Cavinton effect in elderly diabetic patients.
Topics: Aged; Blood Glucose; Brain Ischemia; Diabetic Angiopathies; Diabetic Neuropathies; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Vasodilator Agents; Vinca Alkaloids | 1989 |
[Cavinton treatment of patients with chronic cerebral circulatory insufficiency].
Topics: Adult; Aged; Brain Ischemia; Chronic Disease; Female; Humans; Male; Middle Aged; Vinca Alkaloids | 1986 |
[Hemodynamic disorders and various problems in treatment in strokes with reversible neurologic deficits].
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Bencyclane; Brain Ischemia; Dipyridamole; Diuretics; Drug Therapy, Combination; Female; Hemodynamics; Humans; Male; Middle Aged; Vasodilator Agents; Vinca Alkaloids | 1986 |
[Therapeutic effect of cavinton in chronic cerebral circulatory insufficiency].
Topics: Adult; Aged; Brain Ischemia; Cerebrovascular Circulation; Chronic Disease; Humans; Infusions, Parenteral; Middle Aged; Plethysmography, Impedance; Vertebrobasilar Insufficiency; Vinca Alkaloids | 1985 |